We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$500B
AUM Growth
+$33.8B
Cap. Flow
-$25.4B
Cap. Flow %
-5.08%
Top 10 Hldgs %
30.95%
Holding
15,795
New
1,585
Increased
6,018
Reduced
6,315
Closed
1,626

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.38B
2
NVDA icon
NVIDIA
NVDA
+$732M
3
AMZN icon
Amazon
AMZN
+$606M
4
DIS icon
Walt Disney
DIS
+$559M
5
T icon
AT&T
T
+$466M

Sector Composition

Rank Sector Weight
1 Technology 3.81%
2 Healthcare 2.95%
3 Financials 2.19%
4 Consumer Discretionary 2.15%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKSY.WS icon
13901
BlackSky Technology Inc Warrants
BKSY.WS
$442K
$591 ﹤0.01%
11,821
+1,778
+18% +$117
DNMR
13902
DELISTED
Danimer Scientific, Inc.
DNMR
$588 ﹤0.01%
+14
New +$761
LLYVA icon
13903
CALL
Liberty Live Group Series A
LLYVA
$9.12B
$585 ﹤0.01%
+16
New +$531
BTTX
13904
CALL
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$585 ﹤0.01%
3,000
-1,600
-35% -$348
NHTC icon
13905
PUT
Natural Health Trends
NHTC
$15.8M
$584 ﹤0.01%
100
-3,300
-97% -$18.1K
EUDAW icon
13906
EUDA Health Holdings Warrant
EUDAW
$267K
$582 ﹤0.01%
+10,211
New +$1.13K
CELUW
13907
DELISTED
Celularity Inc
CELUW
$580 ﹤0.01%
14,583
-5,992
-29% -$103
CTEV
13908
PUT
Claritev Corp
CTEV
$414M
$576 ﹤0.01%
10
+7
+233% +$425
BCDAW
13909
DELISTED
BioCardia, Inc. Warrant
BCDAW
$574 ﹤0.01%
45,933
-797
-2% -$70
IDN icon
13910
PUT
Intellicheck
IDN
$76.8M
$570 ﹤0.01%
300
-400
-57% -$760
TLGYW
13911
DELISTED
TLGY Acquisition Corporation Warrant
TLGYW
$567 ﹤0.01%
20,240
+1,400
+7% +$45
MRDB.WS
13912
DELISTED
MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share
MRDB.WS
$565 ﹤0.01%
14,137
+1,405
+11% +$86
TARA icon
13913
CALL
Protara Therapeutics
TARA
$223M
$561 ﹤0.01%
+300
New +$442
SLGL icon
13914
CALL
Sol-Gel Technologies
SLGL
$268M
$553 ﹤0.01%
50
QNTM
13915
PUT
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$19.5M
$552 ﹤0.01%
9
-8
-47% -$563
OMIC
13916
CALL
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$552 ﹤0.01%
40
-233
-85% -$2.76K
BWAQW
13917
DELISTED
Blue World Acquisition Corporation Warrant
BWAQW
$551 ﹤0.01%
17,961
-301
-2% -$22
QUAD icon
13918
PUT
Quad
QUAD
$559M
$542 ﹤0.01%
100
-1,300
-93% -$6.34K
CIA icon
13919
PUT
Citizens
CIA
$236M
$538 ﹤0.01%
200
-100
-33% -$309
SMWB icon
13920
CALL
Similarweb
SMWB
$638M
$533 ﹤0.01%
+100
New +$524
NCTY
13921
PUT
The9 Ltd
NCTY
$69.3M
$524 ﹤0.01%
70
ITI
13922
PUT
DELISTED
Iteris, Inc.
ITI
$520 ﹤0.01%
100
FRLAW
13923
DELISTED
Fortune Rise Acquisition Corporation Warrant
FRLAW
$519 ﹤0.01%
12,098
+290
+2% +$11
PORT.WS
13924
DELISTED
Southport Acquisition Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50
PORT.WS
$513 ﹤0.01%
20,528
-250
-1% -$6
VSACW
13925
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
$511 ﹤0.01%
26,909
+551
+2% +$8

Similar funds

Citadel Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,626 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.

  • Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
  • Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
  • Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
  • Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
  • Citadel Advisors opened 1,585 new positions and closed 1,626 in Q4 2023.
  • Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.